Endpoints News
Plus: Oura’s S-1 is out Read in browser
Endpoints News
Tuesday, 8 September 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
THE BANK THAT TAKES YOU FROM SEED STAGE TO WORLD STAGE
J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most.
sponsored by J.P.Morgan
Health data loading
In the past six months or so, just about every tech giant and tons of digital health startups with apps have been telling users that they can now connect their own medical records so an AI chatbot or assistant can give personalized guidance and other tailored services. 
Google, OpenAI, Amazon, Anthropic, Whoop, Oura… they’re all doing it. About 160 companies have pledged to build AI assistants that leverage medical records, according to CMS.
It’s fascinating that technology and regulatory frameworks have matured enough that this capability is possible. In a new story we’re publishing today, I dig into the trend, what catalyzed it and some of the tensions that are already bubbling up. 
I came away with the sense that when it comes to interoperability, particularly for patient access to data, we are so much further along than just a few years ago. 
But there's still friction: Dominant healthcare organizations aren’t willing to release their grip on patient data completely like consumer apps want them to. And those legacy organizations do make some reasonable points about protecting patient privacy. 
I also still have unanswered questions. Will patients actually want to connect their medical records? There's pervasive skepticism across social media forums about handing personal health data over to big tech companies. People fear their health information being leaked or sold. This trend is new, so I wasn’t able to get a sense of just how many people are taking apps up on the offer. 
Perhaps the most important question is: Will guidance from AI, based on personal health records, actually lead to better health outcomes? I don't think we know yet, and that answer might depend on the type of app. I could see a diabetes-specific program with access to medical records having more luck at helping manage a patient’s condition than a general AI chatbot. But I can also envision some real risks of chatbots getting things wrong.
We’ll have more to come on this topic. Read my story here and let me know if you have more information to share.
- Shelby 
Here’s what’s new
Why consumer apps set their sights on patient health records
Just a few years ago, if you want­ed your full med­ical records, you’d have to re­mem­ber all the places you’ve re­ceived care, go pa­tient por­tal by pa­tient por­tal to re­quest them and try your best to re­call long-for­got­ten pass­words. You might need to trudge to a hos­pi­tal or clin­ic in per­son to ask for your da­ta.

But today, you can download one of dozens of apps that will do the work for you, without any need to remember where you’ve been treated.

It’s part of a revolution for patient access to their own health data in the US, and it’s happening as Americans increasingly turn to ChatGPT and other chatbots to answer their health questions. 
NYC Health Tech Happy Hour
Have you signed up yet for our Health Tech event on Nov. 5?
This week in health Тech
Oura’s S-1 is officially out. We’ll be digging into this more this week, but at first glance, the company is profitable and has been since 2024. For the first nine months of its fiscal year, it booked net income $60.8 million and revenue of $1.2 billion. 
Mental health startup Cerebral is looking for a buyer, Axios reports. Cerebral, which faced an investigation into its controlled substance prescribing practices, bought two companies in the past few years, including a digital therapeutic company.
Cancer care startup Thyme Care raised $125 million, valuing the company at more than $2 billion. Morgan Health led the Series E round.
Too bad we didn’t make it to Telluride this year: The annual film festival debuted a new documentary on Theranos founder Elizabeth Holmes from comedian Nathan Fielder. The trailer is… unsettling.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times